Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens.

Saved in:
Bibliographic Details
Title: Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens.
Authors: Wang Z; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Muecksch F; Laboratory of Retrovirology, The Rockefeller University, New York, NY., Muenn F; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany., Cho A; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Zong S; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Raspe R; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Ramos V; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Johnson B; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Ben Tanfous T; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., DaSilva J; Laboratory of Retrovirology, The Rockefeller University, New York, NY., Bednarski E; Laboratory of Retrovirology, The Rockefeller University, New York, NY., Guzman-Cardozo C; Laboratory of Retrovirology, The Rockefeller University, New York, NY., Turroja M; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Millard KG; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Tober-Lau P; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany., Hillus D; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany., Yao KH; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Shimeliovich I; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Dizon J; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Kaczynska A; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Jankovic M; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Gazumyan A; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Oliveira TY; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Caskey M; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY., Bieniasz PD; Laboratory of Retrovirology, The Rockefeller University, New York, NY.; Howard Hughes Medical Institute, The Rockefeller University, New York, NY., Hatziioannou T; Laboratory of Retrovirology, The Rockefeller University, New York, NY., Kurth F; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany., Sander LE; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany., Nussenzweig MC; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.; Howard Hughes Medical Institute, The Rockefeller University, New York, NY., Gaebler C; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY.; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Source: The Journal of experimental medicine [J Exp Med] 2022 Oct 03; Vol. 219 (10). Date of Electronic Publication: 2022 Aug 25.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1540-9538
DOI:10.1084/jem.20220826